Teladoc Health Inc. ($TDOC) Stock Forecast: Down 5.3% Today

What is Teladoc Health Inc.?

Teladoc Health is a telehealth company that provides virtual healthcare services to patients, offering a range of medical specialties through remote consultations.

Why is Teladoc Health Inc. going down?

TDOC stock is down 5.3% on Mar 27, 2026 15:43

• Teladoc Health (TDOC) experienced a bearish movement today, underperforming the broader market, despite showing a strong climb over the past month.
• The decrease in stock price could be attributed to a price target revision from an analyst, reflecting concerns about the company's future growth and profitability.
• Analysts' revised estimates for TDOC's upcoming earnings report, anticipating a decline in EPS and revenue year-over-year, might have contributed to the negative market sentiment.
• Despite the recent dip, the long-term outlook for Teladoc Health remains positive, given the projected significant growth in the Digital Health market and the company's strategic initiatives to expand its virtual care offerings and partnerships.

TDOC Price Chart

TDOC Technical Analysis

TDOC News

Teladoc Health pilots bedside and virtual nurse model at AONL2026

Teladoc Health has announced a new hybrid care model at AONL2026, combining bedside and virtual nurses to address staffing shortages and boost retention in the healthcare sector. This initiative aims to improve care delivery by integrating in-person expertise with remote support. The company continues to expand its virtual care offerings, including partnerships with VSP Vision and a Medicare-focused virtual Diabetes Prevention Program.

https://tradersunion.com/news/companies/show/1804774-teladoc-hybrid-care-model/

Teledoc (TDOC) Gets a $7 Price Target From Barclays: Can It Double From Recent Lows?

Barclays has cut its price target for Teladoc (TDOC) to $7 from $8.50, maintaining an Equal Weight rating, despite the stock having recovered from its lows. The company's future growth hinges on the success of BetterHelp's transition to an insurance-based delivery model and the stabilization of Integrated Care membership. Achieving the $7 target, which implies a market capitalization of $1.25 billion, requires robust performance in BetterHelp's insurance scaling and overall profitability improvements.

https://247wallst.com/investing/2026/03/26/teledoc-tdoc-gets-a-7-price-target-from-barclays-can-it-double-from-recent-lows/

Barclays Maintains Rating, Lowers Price Target for TDOC | TDOC S

Barclays has maintained an "Equal-Weight" rating for Teladoc Health (TDOC) but lowered its price target from $8.50 to $7.00. This adjustment reflects a 17.65% decrease and follows similar actions by other firms like JP Morgan and Oppenheimer, though Deutsche Bank upgraded TDOC to "Buy." The telehealth company's average target price from analysts is $6.95, suggesting a potential upside of 24.78% from its current price, while GuruFocus estimates a fair value of $9.15.

https://www.gurufocus.com/news/8746667/barclays-maintains-rating-lowers-price-target-for-tdoc-tdoc-stock-news

Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Teladoc (TDOC) experienced a dip, underperforming the broader market but showed a strong climb over the past month. Investors are anticipating its upcoming earnings report, with current estimates forecasting a decline in EPS and revenue year-over-year. Analysts have recently revised their EPS estimates upward, leading to a Zacks Rank of #3 (Hold) for the company.

https://sg.finance.yahoo.com/news/teladoc-tdoc-sees-more-significant-221503126.html

Digital Health Market Is Going to Boom| Teladoc Health, American Well Corporation, and Doctor on Demand

The Digital Health market is projected to grow significantly from USD 350.42 billion in 2025 to USD 1,143.01 billion by 2032, at a CAGR of 18.4%. This growth is attributed to increasing demand, an expanding customer base, and technological advancements. A new report by Coherent Market Insights provides a comprehensive analysis of the market, including competitive landscape, segmentation, and global growth opportunities.

https://www.openpr.com/news/4437720/digital-health-market-is-going-to-boom-teladoc-health-american

Trending Today

Palantir Technologies Inc ($PLTR) Stock Forecast: Up 5.6% Today

Oracle Corporation ($ORCL) Stock Forecast: Up 5.3% Today

Exxon Mobil Corporation ($XOM) Stock Forecast: Down 3.3% Today

Broadcom Inc. ($AVGO) Stock Forecast: Up 5.4% Today

Taiwan Semiconductor Manufacturing Company Ltd. ($TSM) Stock Forecast: Up 5.2% Today

Devon Energy Corporation ($DVN) Stock Forecast: Down 4.1% Today

Energy Transfer LP ($ET) Stock Forecast: Down 2.2% Today

EOG Resources Inc. ($EOG) Stock Forecast: Down 4.0% Today

ConocoPhillips ($COP) Stock Forecast: Down 1.7% Today

Chevron Corporation ($CVX) Stock Forecast: Down 3.1% Today

Teladoc Health Inc. Price History

13.01.2026 - TDOC Stock was up 6.8%

• TDOC stock experienced a bullish movement today, likely driven by positive developments and partnerships in the telehealth industry.
• The announcement of the retirement of a long-serving board director may have been perceived positively by investors, signaling potential for new perspectives and growth opportunities within the company.
• The expansion of virtual care access through the HealthKey partnership underscores Teladoc Health's commitment to addressing healthcare disparities, which could have boosted investor confidence in the company's long-term vision and growth prospects.
• The bullish market movement for TDOC aligns with the overall positive outlook for the telemedicine sector, as highlighted by the projected significant growth of the global telemedicine and digital health markets in the coming years.

10.02.2026 - TDOC Stock was up 10.3%

• Teladoc Health's stock saw a strong bullish movement today.
• An inducement award to Daniel Conroy, the new Chief Growth Officer, U.S. Group Health, was announced under NYSE Rule 303A.08, potentially boosting investor confidence in the company's growth.
• The award, comprising restricted stock units and performance stock units tied to three-year targets, aligns Conroy's compensation with Teladoc's growth strategies, highlighting a focus on market expansion and financial performance.
• Despite a recent increase in short interest, Teladoc Health's positive developments and strategic initiatives appear to have outweighed any concerns, driving the bullish market activity.

06.01.2026 - TDOC Stock was up 5.1%

• Teladoc Health's strong bullish movement today could be attributed to the positive sentiment surrounding its efforts to enhance hypertension care through telemedicine services, showcasing its commitment to improving patient outcomes.
• The upcoming announcement of Teladoc Health's fourth-quarter 2025 financial results might have sparked investor optimism, leading to increased buying activity and driving the stock higher.
• Despite recent price drops and concerns about lacklustre performance, the market may be reacting positively to the potential growth opportunities in the digital therapeutics industry, where Teladoc Health plays a significant role.
• Jim Cramer's bearish outlook on Teladoc Health, citing reasons to sell the stock, could have initially caused some uncertainty; however, the market's response today indicates a divergence from this sentiment, potentially driven by a focus on the company's innovative healthcare solutions and future growth prospects.

19.01.2026 - TDOC Stock was up 5.6%

• Teladoc Health (TDOC) experienced a strong bullish movement today, likely driven by positive market sentiment and potential growth opportunities in its U.S. Integrated Care segment.
• Concerns were raised about peer multiple compression and soft Sensor Tower trends impacting revenue expectations, but the appointment of experienced executive Michael Smith to the board of directors may have instilled confidence in the company's long-term strategic focus and growth prospects.
• The market may be reacting positively to the anticipation of Teladoc's Q4 2025 earnings report, with analysts expecting growth in members and adjusted EBITDA in the U.S. Integrated Care segment, potentially offsetting declines in other areas.
• Despite price target reductions from various financial institutions due to industry challenges, the overall outlook for Teladoc Health remains positive, especially with a focus on innovation in virtual care and strategic transformations aligning with the company's mission.

27.01.2026 - TDOC Stock was down 5.2%

• Teladoc Health (TDOC) witnessed a strong bearish movement despite recent positive developments and financial improvements.
• The bullish upgrade by BofA Securities and narrowing Q4 losses suggested future profitability, but caution from analysts and multiple price target reductions affected the stock.
• Analysts' conflicting signals, with some cutting forecasts despite solid financial performance, led to investor uncertainty and a bearish market trend.
• Challenges in the BetterHelp segment and declining U.S. revenues likely impacted the negative sentiment, despite positive international growth and cost-saving efforts.

12.01.2026 - TDOC Stock was down 5.0%

• The collaboration with HealthKey indicates Teladoc Health's dedication to reducing healthcare disparities through extended virtual care access. However, market reaction possibly reflects worries about heightened competition and potential margin challenges.
• Positive growth forecasts for telemedicine and digital health sectors suggest a promising industry outlook. Nonetheless, stock performance of TDOC might be impacted by general market trends or company-specific issues.
• The decrease in Hims & Hers Health Inc. (HIMS) stock and advice to lower exposure could signal cautiousness towards telehealth firms, potentially influencing TDOC's stock performance.
• Despite optimistic industry growth forecasts, concerns about regulatory reviews on specific medications and competitive pressures outlined elsewhere might have raised worries among investors regarding TDOC's future profitability and market standing. This could have contributed to the observed bearish market movement today.

11.01.2026 - TDOC Stock was down 9.2%

• Today's decline in TDOC's stock price could be attributed to profit-taking by investors following a period of increased bullish activity in the options market.
• Concerns about Teladoc's financial health, including negative ROE and financial distress indicators, may have contributed to the stock's downward pressure despite positive long-term growth prospects for the telemedicine industry.
• The market response may be tied to valuation metrics indicating that TDOC's stock is currently trading near historical lows for its price-to-sales and price-to-book ratios, prompting questions about its current valuation and potential future growth.
• Despite the overall positive outlook for the telehealth market and the innovation and growth driven by key players, individual company performance and financial metrics like those of Teladoc can still impact short-term stock movements.

05.01.2026 - TDOC Stock was down 5.6%

• Teladoc Health's stock faced a significant bearish trend today, which could have been influenced by:
• Negative remarks by Jim Cramer, suggesting investors to sell due to fierce competition in the virtual medical care industry and more lucrative opportunities in AI stocks.
• Substantial stock price declines in the last month and year, indicating diminished investor confidence and future growth prospects.
• Despite being listed as one of the 2021 TIME100 Most Influential Companies, concerns about Teladoc's future competitiveness in the telehealth sector might be impacting its stock performance.
• The perception shift of Teladoc as an infrastructure investment rather than a high-growth stock, potentially undermining investor faith in the company's ability to deliver swift returns.

26.01.2026 - TDOC Stock was up 12.4%

• Teladoc Health's stock saw significant upward movement today, possibly driven by overall positive sentiment following the company's Q4 2025 results surpassing analyst expectations.
• Despite exceeding revenue projections and showing positive adjusted EBITDA, the stock initially showed little change post-earnings report. This could be due to concerns stemming from weaker-than-anticipated guidance for Q1 CY2026 revenue, as well as EPS and EBITDA for the whole of 2026.
• The rise in Teladoc Health's stock price after hours, preceding its upcoming earnings report on February 25, 2026, suggests short-term trader positioning and optimism despite ongoing net losses and a year-to-date weakness.
• Price target reductions by BofA Securities and Goldman Sachs in January 2026 might have initially impacted investor confidence negatively. However, today's positive market movement indicates a resurgence of interest in the company's potential for long-term growth.

23.02.2026 - TDOC Stock was up 2.0%

• Teladoc Health (TDOC) saw a significant bullish movement recently due to various factors:
• Despite releasing a mix of financial results and providing a cautious short-term outlook, the company raised its full-year forecast and witnessed an 8.5% increase in its user base to 101.8 million.
• Focusing on BetterHelp and chronic care, as well as expanding its platform's reach, has positively reshaped Teladoc's investment narrative, offsetting worries about competition and compliance costs.
• Investors are recognizing Teladoc's potential undervaluation, with a lower P/S ratio compared to industry peers, showing confidence in the company's growth potential in the virtual care sector.

11.02.2026 - TDOC Stock was down 5.4%

• Teladoc Health's stock faced downward pressure today, despite positive developments and upgrades from analysts.
• Investor sentiment was dampened by the company's conservative outlook for upcoming periods and pessimistic earnings per share guidance for Q1 and FY2026.
• Analysts gave mixed reviews, with some raising the stock's rating based on valuation and potential exit strategies, while others remained wary of market saturation and long-term challenges.
• Following the analyst upgrades, the initial spike in share price may have been brief, as market sentiment continues to be uncertain, driven by apprehensions about profitability and insider trading activity.

27.02.2026 - TDOC Stock was down 5.3%

• Teladoc Health (TDOC) experienced a bearish movement today, underperforming the broader market, despite showing a strong climb over the past month.
• The decrease in stock price could be attributed to a price target revision from an analyst, reflecting concerns about the company's future growth and profitability.
• Analysts' revised estimates for TDOC's upcoming earnings report, anticipating a decline in EPS and revenue year-over-year, might have contributed to the negative market sentiment.
• Despite the recent dip, the long-term outlook for Teladoc Health remains positive, given the projected significant growth in the Digital Health market and the company's strategic initiatives to expand its virtual care offerings and partnerships.